229 related articles for article (PubMed ID: 16326716)
1. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
Khalil IA; Kogure K; Futaki S; Harashima H
J Biol Chem; 2006 Feb; 281(6):3544-51. PubMed ID: 16326716
[TBL] [Abstract][Full Text] [Related]
2. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.
Fujiwara T; Akita H; Harashima H
Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779
[TBL] [Abstract][Full Text] [Related]
3. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape.
El-Sayed A; Khalil IA; Kogure K; Futaki S; Harashima H
J Biol Chem; 2008 Aug; 283(34):23450-61. PubMed ID: 18550548
[TBL] [Abstract][Full Text] [Related]
4. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
6. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
Mudhakir D; Akita H; Tan E; Harashima H
J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
[TBL] [Abstract][Full Text] [Related]
7. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
Khalil IA; Kogure K; Futaki S; Harashima H
Int J Pharm; 2008 Apr; 354(1-2):39-48. PubMed ID: 18242018
[TBL] [Abstract][Full Text] [Related]
8. Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus.
Akita H; Enoto K; Masuda T; Mizuguchi H; Tani T; Harashima H
Mol Ther; 2010 May; 18(5):955-64. PubMed ID: 20216528
[TBL] [Abstract][Full Text] [Related]
9. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
10. Octaarginine-modified liposomes enhance cross-presentation by promoting the C-terminal trimming of antigen peptide.
Nakamura T; Ono K; Suzuki Y; Moriguchi R; Kogure K; Harashima H
Mol Pharm; 2014 Aug; 11(8):2787-95. PubMed ID: 24901376
[TBL] [Abstract][Full Text] [Related]
11. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
12. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
[TBL] [Abstract][Full Text] [Related]
13. Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature.
Iwasa A; Akita H; Khalil I; Kogure K; Futaki S; Harashima H
Biochim Biophys Acta; 2006 Jun; 1758(6):713-20. PubMed ID: 16780792
[TBL] [Abstract][Full Text] [Related]
14. Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy.
Akita H; Ito R; Khalil IA; Futaki S; Harashima H
Mol Ther; 2004 Mar; 9(3):443-51. PubMed ID: 15006612
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement.
Nakase I; Niwa M; Takeuchi T; Sonomura K; Kawabata N; Koike Y; Takehashi M; Tanaka S; Ueda K; Simpson JC; Jones AT; Sugiura Y; Futaki S
Mol Ther; 2004 Dec; 10(6):1011-22. PubMed ID: 15564133
[TBL] [Abstract][Full Text] [Related]
16. Octaarginine-modified liposomes enhance the anti-oxidant effect of Lecithinized superoxide dismutase by increasing its cellular uptake.
Furukawa R; Yamada Y; Takenaga M; Igarashi R; Harashima H
Biochem Biophys Res Commun; 2011 Jan; 404(3):796-801. PubMed ID: 21168389
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition.
Koshkaryev A; Piroyan A; Torchilin VP
Cancer Lett; 2013 Jul; 334(2):293-301. PubMed ID: 22743614
[TBL] [Abstract][Full Text] [Related]
18. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice.
Mudhakir D; Akita H; Khalil IA; Futaki S; Harashima H
Drug Metab Pharmacokinet; 2005 Aug; 20(4):275-81. PubMed ID: 16141607
[TBL] [Abstract][Full Text] [Related]
20. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
